Home monitoring for patients with pulmonary fibrosis
Official title: The SUITS Study: Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
Run by Erasmus Medical Center · NCT06883448 · Data updated 2026-11-12
This study tests if using home monitoring and video calls can help people with pulmonary fibrosis manage their condition as well as or better than regular clinic visits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 11 sites (Amsterdam and 10 other locations) |
| Status | Recruiting |
| Started | October 2, 2024 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | May 27, 2026 |
| Trial ID | NCT06883448 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults diagnosed with pulmonary fibrosis who can engage with the home monitoring program.
✕Probably not a fit
Patients who cannot communicate in Dutch or lack internet access may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of replacing half of the outpatient clinic visits for pulmonary fibrosis patients with home monitoring and video consultations. Participants will be randomly assigned to either traditional hospital-based care or a home monitoring program that includes weekly health measurements and remote consultations. The home monitoring program features tools like home spirometry, pulse-oximetry, and a mobile health application for tracking patient-reported outcomes. The study will last for 12 months, with questionnaires administered at set intervals to assess health outcomes.
Why it matters
Potential benefit: If successful, this approach could enhance patient self-management and improve health outcomes for those with pulmonary fibrosis.
How similar studies have gone: Other studies have shown promise in using home monitoring and telehealth approaches for chronic conditions, suggesting potential success for this method.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A multidisciplinary ILD team diagnosis of pulmonary fibrosis according to ATS/ERS/JRS/ALAT guidelines; * Adults (=/\>18 years). Exclusion Criteria: * Patients who are not able to speak, read and/or write in Dutch; * Patients with no access to the internet; * Patients with a life expectancy of less than 1 year as determined by the treating healthcare provider; * Patients who are or have been using a home monitoring program for PF.
Where it's running
-
Department of Pulmonology, Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands Recruiting -
Department of Pulmonary Diseases, Rijnstate Hospital
Arnhem, Netherlands Recruiting -
Department of Respiratory Medicine, Amphia Hospital
Breda, Netherlands Recruiting -
Department of Respiratory Medicine, Catharina Hospital
Eindhoven, Netherlands Recruiting -
Department of Pulmonary Medicine, Zuyderland Medical Centre
Heerlen, Netherlands Recruiting -
Department of Pulmonology, Medical Center Leeuwarden
Leeuwarden, Netherlands Recruiting
Show 5 more locations
-
Department of Pulmonology, Leiden University Medical Center
Leiden, Netherlands Recruiting -
Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital
Nieuwegein, Netherlands Recruiting -
Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center
Rotterdam, Netherlands Recruiting -
Department of Pulmonology, Haaglanden Medisch Centrum
The Hague, Netherlands Recruiting -
Division of Heart and Lungs, University Medical Center Utrecht and Utrecht University
Utrecht, Netherlands Recruiting
Study contacts
- Principal investigator: Marlies S. Wijsenbeek-Lourens, Prof Dr — Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, The Netherlands
- Study coordinator: Delian E. Hofman
- Email: d.hofman@erasmusmc.nl
- Phone: +31650162675
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Routine versus on-demand ECMO during lung transplant
This trial tests whether using ECMO routinely during lung transplant or only when needed leads to fewer complications for people having a lung transplant.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Photon-counting CT vs standard HRCT to help diagnose IPF and other ILDs
This study tests whether photon-counting CT can improve identifying IPF and other ILDs compared with standard HRCT for patients discussed in multidisciplinary teams.
-
AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CT
This study tests how well the AccuPulmo CT Portal can identify pulmonary fibrosis on existing chest CT scans from adults at Taichung Veterans General Hospital.
-
Finger vs. Earlobe Pulse Oximetry During a 6-Minute Walk Test in ILD
This study tests whether finger or earlobe pulse oximetry gives the same oxygen saturation readings during a 6-minute walk in people with interstitial lung disease.
-
Tele-Pulmonary Rehabilitation for Chronic Lung Diseases
This study tests whether a remote tele-rehabilitation program helps people with chronic lung diseases start and stick with pulmonary rehab better than usual center-based care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.